Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.

The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Abstract Text:

    alissa walshAlissa Walsh,jeannette l dixonJeannette L Dixon,grant a rammGrant A Ramm,david g hewettDavid G Hewett,douglas j lincolnDouglas J Lincoln,gregory j andersonGregory J Anderson,v nathan subramaniamV Nathan Subramaniam,julian dodemaideJulian Dodemaide,juleen a cavanaughJuleen A Cavanaugh,mark l bassettMark L Bassett,lawrie w powellLawrie W Powell,

    BACKGROUND & AIMS: Two major mutations are defined within the hemochromatosis gene, HFE. Although the effects of the C282Y substitution have been well characterized, the clinical significance of the C282Y/H63D state remains unclear. This study assessed the phenotypic expression in C282Y/H63D subjects as compared with C282Y homozygotes. METHODS: Data were obtained from 91 C282Y/H63D probands, 158 C282Y/H63D subjects identified through family screening, and 483 C282Y homozygotes. Subjects underwent clinical evaluation, genotyping, biochemical assessment, and liver biopsy examination where clinically indicated. RESULTS: C282Y/H63D probands had significantly less clinical and biochemical expression than C282Y homozygotes. Biochemical expression was higher in C282Y/H63D probands than in C282Y/H63D subjects identified through family screening (P < .001). Of the C282Y/H63D subjects with serum ferritin levels greater than 1000 mug/L, all had known comorbid factors that could have contributed to the increased ferritin level. Of the 51 C282Y/H63D subjects who underwent liver biopsy examination, significantly increased iron stores were present in 9 subjects and hepatic fibrosis was present in 13. Twelve of the 13 had evidence of hepatic steatosis, excess alcohol consumption, or diabetes. The mobilizable iron level was significantly higher in C282Y homozygous males than in compound heterozygous males (P < .001). Genetic screening of C282Y/H63D first-degree relatives detected 5 C282Y homozygotes. CONCLUSIONS: C282Y/H63D subjects referred for assessment had a high prevalence of increased iron indices but did not develop progressive clinical disease without comorbid factors such as steatosis, diabetes, or excess alcohol consumption. When fibrosis was seen, 1 or more comorbid factors almost always were present. Thus, phlebotomy therapy is warranted and cascade screening of relatives should be performed because expressing C282Y homozygotes may be detected.

    The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Publishing Authors By Initials

    a walshA Walsh,jl dixonJL Dixon,ga rammGA Ramm,dg hewettDG Hewett,dj lincolnDJ Lincoln,gj andersonGJ Anderson,vn subramaniamVN Subramaniam,j dodemaideJ Dodemaide,ja cavanaughJA Cavanaugh,ml bassettML Bassett,lw powellLW Powell,

    For similar genetic phenomena: phenotype research abstracts see: genetic phenomena: phenotype research

    PUBMED ID PMID:

    MEDLINE DATE:

    The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Clinical gastroenterology and hepatology : the off

    VOLUME: 4

    Page Numbers: 1403-10

    Journal Abbreviation: Clin. Gastroenterol. Hepatol.

    ISSN: 1542-3565

    DAY: 18

    MONTH: 09

    YEAR: 2006

    The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101160775

    The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Keywords Mesh Terms:

    KEYWORDS: Phenotype

    MESH TERMS: genetics

    Chemical & Substance for Abstract: The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Information

    Substance Name: Ferritins

    Registry Number: 9007-73-2

    Grant and Affiliation Information for The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.

    AFFILIATION: The Department of Gastroenterology & Hepatology, Royal Brisbane & Women's Hospital, Brisbane, Australia.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIDDK

    GRANT: 5R01DK057648-04

    ACRONYM: DK

    MEDLINETA: Clin Gastroenterol Hepatol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News